A single-arm open-labelled clinical study to evaluate the efficacy of guduchi siddhaksheer ghrut basti in katisandhigata vata w.s.r. to lumbar spondylosis.
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 45
- Locations
- 1
- Primary Endpoint
- Katishoola
Study Overview
Brief Summary
Nowadays humans are suffering from many lifestyle-related disorders due to the adaption of modern
lifestyle. Katisandhigata vata is one of them. It is not only clinical but also social, economic & public health
problems affecting the general population indiscriminately. It is not a life-threatening condition, but it
causes great discomfort and restriction in social and other activities [3]. 25% of females are prone to
Sandhigata Vata where whereas 16% of males are affected due to it. Conventional treatments, including
pharmacological interventions and physical therapy, often provide limited relief and may be associated with
side effects. Guduchi siddhaksheer ghrut basti, an ayurvedic therapeutic procedure involves the
administration of medicated Ksheerbasti prepared with guduchi. This study aims to evaluate the
effectiveness of guduchi siddhaksheer ghrut basti in managing symptoms of lumbar spondylosis, potentially
offering a holistic and safer alternative to conventional treatment.
Study Design
- Study Type
- Interventional
- Allocation
- Random Number Table
- Masking
- Not Applicable
Eligibility Criteria
- Ages
- 18.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patients having classical signs and symptoms of Katisandhigata Vata.
- •(Niraam avastha) a.
- •Katishoola (pain in low back) b.
- •Katistambha (stiffness of lower back) c.
- •Akunchana Prasarana Pravrutti Savedana (painful joint movements) Patients aged between 18 and 60 years and all genders.
- •Diagnosed with lumbar spondylosis based on clinical and radiological finding.
- •Willingness to participate and provide informed consent.
Exclusion Criteria
- •Patients with acute lumbar spine injuries or fractures.
- •Presence of systemic diseases such as diabetes, rheumatoid arthritis, CA, or any major autoimmune disorder Pregnant or lactating women.
- •Patients not willing to consent.
- •Patient not eligible for basti karma.
Outcomes
Primary Outcomes
Katishoola
Time Frame: 14 days
Secondary Outcomes
- Katistambha(Akunchana Prasarana Pravrutti Savedana)